Skip to main content
. 2017 Aug 11;7:7885. doi: 10.1038/s41598-017-07392-5

Figure 4.

Figure 4

Schematic multi-axial profiling of β-AR agonist efficacies and potencies at G protein activation with different Gα expression levels. (ad) ISO, NE or EPI potencies (a,b) or maximal efficacies (c,d) at G protein (Gαs, Gαi1, GαoA) activation upon stimulation of β1-AR (a,c) or β2-AR (b,d) presented in Fig. 3 and Supplementary Tables 2 and 3 are shown in a web.